Equities Analysts Issue Forecasts for MTD FY2024 Earnings

Mettler-Toledo International Inc. (NYSE:MTD) – Zacks Research increased their FY2024 earnings per share estimates for Mettler-Toledo International in a research report issued to clients and investors on Thursday, November 28th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will post earnings of $40.40 per share for the year, up from their previous estimate of $40.28. The consensus estimate for Mettler-Toledo International’s current full-year earnings is $40.42 per share. Zacks Research also issued estimates for Mettler-Toledo International’s Q2 2025 earnings at $10.34 EPS, FY2025 earnings at $42.39 EPS, Q3 2026 earnings at $11.88 EPS and FY2026 earnings at $48.78 EPS.

Several other equities research analysts also recently commented on the stock. Wells Fargo & Company dropped their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Stifel Nicolaus cut their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Finally, Robert W. Baird cut their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $1,338.75.

Mettler-Toledo International Price Performance

Shares of NYSE MTD opened at $1,257.86 on Monday. The stock has a market capitalization of $26.54 billion, a PE ratio of 33.91, a P/E/G ratio of 4.15 and a beta of 1.13. Mettler-Toledo International has a one year low of $1,068.33 and a one year high of $1,546.93. The business’s fifty day moving average price is $1,338.57 and its 200-day moving average price is $1,388.61.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million.

Insiders Place Their Bets

In related news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares in the company, valued at approximately $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.94% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

A number of large investors have recently modified their holdings of MTD. Gateway Investment Advisers LLC purchased a new stake in Mettler-Toledo International during the second quarter valued at about $685,000. SG Americas Securities LLC lifted its holdings in Mettler-Toledo International by 52.9% in the 2nd quarter. SG Americas Securities LLC now owns 4,516 shares of the medical instruments supplier’s stock worth $6,312,000 after buying an additional 1,562 shares during the period. Allspring Global Investments Holdings LLC grew its position in shares of Mettler-Toledo International by 14.0% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock worth $1,860,000 after buying an additional 152 shares during the last quarter. Linden Thomas Advisory Services LLC increased its stake in shares of Mettler-Toledo International by 212.2% during the second quarter. Linden Thomas Advisory Services LLC now owns 1,308 shares of the medical instruments supplier’s stock valued at $1,828,000 after buying an additional 889 shares during the period. Finally, Federated Hermes Inc. raised its holdings in shares of Mettler-Toledo International by 10.3% during the second quarter. Federated Hermes Inc. now owns 7,667 shares of the medical instruments supplier’s stock valued at $10,715,000 after acquiring an additional 717 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.